The type-1 diabetes mellitus resistant ZnT8 specific antibody C22 is screened and authenticated and can be used for diagnosing and treating type-1 diabetes mellitus and/or preparing prognosis reagents.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1754z | Recombinant Anti-Human SLC30A10 Antibody | WB, IF, FuncS | IgG |
HPAB-M0205-YC | Human Anti-SLC30A10 Recombinant Antibody (clone C22) | ELISA, WB, IHC | Humanized IgG |
HPAB-M0206-YC | Human Anti-SLC30A10 Recombinant Antibody (clone C27) | ELISA, WB, IHC | Human IgG |
There are currently no Customer reviews or questions for HPAB-M0205-YC-S(P). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.